Skip to main content
Premium Trial:

Request an Annual Quote

Applied Precision Signs Distribution Deal with GeneScan Europe

NEW YORK, March 19 – Applied Precision of Issaquah, Wash., said Monday that Freiburg, Germany-based GeneScan Europe had been given the rights to exclusively distribute its ArrayWorx Microarray Scanner in Europe, Australia, and New Zealand.

"GeneScan is a major player in applied molecular biology in Europe, which will provide invaluable assistance to us in expanding our market share in these countries," Joe Ahladis, vice president of sales, marketing, and customer service for Applied Precision, said in a statement.

GeneScan’s subsidiary BioChip Technologies currently uses the ArrayWorx scanner for higher density arrays. The company uses its own microarray reader, Biodetect, for lower density arrays.

Terms of the deal were not disclosed, but the companies said it was a “long-term” partnership.

GeneScan Europe, one of 13 biotechnology companies within the GeneScan group, provides products and services in applied molecular biology and develops customized biochips with low to medium spot densities.

Applied Precision develops measurement, analysis, and process control systems for biomedical and biotechnology imaging and analysis systems. Harvard University’s Bauer Center for Genomic Research is one of the users of ArrayWorx.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.